Lab
Holy Family Memorial INC
Holy Family Memorial INC was paid $697K by Medicaid between Jan 2018 and Dec 2024, across 68 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 21% of everything it billed.
33Billing provider infoHOLY FAMILY MEMORIAL INC
MANITOWOC, WI 54220
MANITOWOC, WI 54220
33aNPI1336314632assigned 04/28/2008
33bProvider typeClinical Medical Laboratory
28Total paid$697K
24GClaims57,693
24DCodes billed68
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Wisconsin
Rank by total paid#26 of 75
Median peer was paid$106K
This provider vs. median6.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,624 | $92K | |
| 2019 | 10,794 | $85K | |
| 2020 | 11,597 | $197K | |
| 2021 | 13,576 | $216K | |
| 2022 | 5,596 | $61K | |
| 2023 | 2,915 | $26K | |
| 2024incomplete | 2,591 | $19K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 21% | 1,826 | 1,612 | $143K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 8.1% | 1,442 | 1,261 | $57K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6.5% | 1,012 | 798 | $45K |
| 80061 | Lipid panel | 5.5% | 3,859 | 3,463 | $38K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 4.8% | 828 | 646 | $33K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.6% | 1,159 | 1,020 | $32K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.3% | 1,157 | 1,018 | $30K |
| 80053 | Comprehensive metabolic panel | 4.2% | 3,594 | 3,089 | $30K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.0% | 4,427 | 3,756 | $28K |
| 80050 | General health panel | 3.9% | 771 | 702 | $27K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.1% | 1,705 | 1,519 | $21K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.9% | 2,877 | 2,373 | $20K |
56 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.8% | 1,582 | $20K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.8% | 2,742 | $20K |
| 87631 | 2.7% | 196 | $19K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.5% | 932 | $18K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.5% | 1,665 | $10K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 111 | $7K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.0% | 68 | $7K |
| 81001 | <1% | 2,658 | $7K | |
| 87634 | <1% | 138 | $6K | |
| 81025 | <1% | 893 | $6K | |
| 87081 | <1% | 865 | $5K | |
| 84439 | <1% | 762 | $5K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 150 | $5K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 182 | $5K |
| 87660 | <1% | 342 | $5K | |
| 85027 | <1% | 846 | $5K | |
| 87480 | <1% | 342 | $4K | |
| 83655 | <1% | 400 | $4K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 246 | $4K |
| 87510 | <1% | 342 | $4K | |
| 86140 | <1% | 844 | $4K | |
| 87186 | <1% | 375 | $3K | |
| 85652 | <1% | 816 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 144 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 21 | $2K |
| 85018 | <1% | 779 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,178 | $1K |
| 82607 | <1% | 109 | $1K | |
| 81003 | <1% | 734 | $1K | |
| 85007 | <1% | 404 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 30 | $1K |
| 88142 | <1% | 46 | $898.78 | |
| 87340 | <1% | 127 | $797.33 | |
| 85610 | <1% | 154 | $563.87 | |
| 86780 | <1% | 57 | $488.20 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 13 | $474.96 |
| 82043 | <1% | 114 | $450.59 | |
| 87070 | <1% | 50 | $443.50 | |
| 80076 | <1% | 53 | $362.95 | |
| 87625 | <1% | 16 | $314.96 | |
| 87205 | <1% | 50 | $225.05 | |
| 83735 | <1% | 35 | $198.26 | |
| 87077 | <1% | 42 | $195.38 | |
| 86803 | <1% | 17 | $123.03 | |
| 87210 | <1% | 42 | $115.75 | |
| 83690 | <1% | 12 | $99.20 | |
| 83550 | <1% | 15 | $94.09 | |
| 87088 | <1% | 13 | $89.89 | |
| 83540 | <1% | 15 | $69.65 | |
| 82947 | <1% | 16 | $41.52 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 1,882 | $18.91 |
| 36416 | <1% | 101 | $9.09 | |
| 80348 | 0% | 46 | $0.00 | |
| 80363 | 0% | 94 | $0.00 | |
| 80358 | 0% | 97 | $0.00 | |
| 80324 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRAF, BRIAN (VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Holy Family Memorial INC | Manitowoc, WI | $5.03M |
| Holy Family Memorial INC | Manitowoc, WI | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.